{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:14:41Z","timestamp":1790957681244,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jacep.2022.04.010","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T17:08:45Z","timestamp":1655744925000},"page":"763-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Role for Ranolazine in the Treatment of Ventricular Arrhythmias?"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8493-5123","authenticated-orcid":false,"given":"Jason G.","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc W.","family":"Deyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2022.04.010_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.hrthm.2011.03.045","article-title":"Electrophysiologic basis for the antiarrhythmic actions of ranolazine","volume":"8","author":"Antzelevitch","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2022.04.010_bib2","doi-asserted-by":"crossref","first-page":"174787","DOI":"10.1016\/j.ejphar.2022.174787","article-title":"Role of ranolazine in heart failure: from cellular to clinic perspective","volume":"919","author":"Kaplan","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacep.2022.04.010_bib3","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non\u2013ST-elevation acute coronary syndromes: the MERLIN\u2013TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacep.2022.04.010_bib4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2018.04.086","article-title":"Ranolazine in high-risk patients with implanted cardioverter-defibrillators","volume":"72","author":"Zareba","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2022.04.010_bib5","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1161\/CIRCULATIONAHA.119.042622","article-title":"Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring","volume":"140","author":"Andrade","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2022.04.010_bib6","first-page":"754","article-title":"Reduction in ventricular tachyarrhythmia burden in patients enrolled in the RAID trial","volume":"8","author":"Younis","year":"2022","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacep.2022.04.010_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology","volume":"44","author":"Amorim","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacep.2022.04.010_bib8","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/CIRCRESAHA.116.304493","article-title":"Sudden cardiac death risk stratification","volume":"116","author":"Deyell","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacep.2022.04.010_bib9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jelectrocard.2018.09.009","article-title":"Ejection fraction in left bundle branch block is disproportionately reduced in relation to amount of myocardial scar","volume":"51","author":"Axelsson","year":"2018","journal-title":"J\u00a0Electrocardiol"},{"key":"10.1016\/j.jacep.2022.04.010_bib10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.hrthm.2019.03.027","article-title":"Pacing in proximity to scar during cardiac resynchronization therapy increases local dispersion of repolarization and susceptibility to ventricular arrhythmogenesis","volume":"16","author":"Mendonca Costa","year":"2019","journal-title":"Heart Rhythm"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X22003310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X22003310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:30:04Z","timestamp":1762500604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X22003310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2405500X22003310"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2022.04.010","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Role for Ranolazine in the Treatment of Ventricular Arrhythmias?","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2022.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}